ICU Medical Inc(ICUI) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Oct 28 at 4:00 PM ET (Korea 10/29 05:00)
Full metrics table
| Index | RUT | P/E | 140.56 | EPS (ttm) | 1.18 | Insider Own | 1.77% | Shs Outstand | 25.0M | Perf Week | 3.45% |
| Market Cap | 4.16B | Forward P/E | 17.21 | EPS next Y | 10.61% | Insider Trans | -9.14% | Shs Float | 24.6M | Perf Month | 1.8% |
| Enterprise Value | 5.15B | PEG | 1.68 | EPS next Q | 2.14 | Inst Own | 104.66% | Short Float | 6.97% | Perf Quarter | -1.18% |
| Income | 0.03B | P/S | 1.93 | EPS this Y | 12.63% | Inst Trans | 0.67% | Short Ratio | 6.42 | Perf Half Y | 44.12% |
| Sales | 2.16B | P/B | 1.93 | EPS next 5Y | 10.24% | ROA | 0.74% | Short Interest | 1.71M | Perf YTD | 16.63% |
| Book/sh | 86.05 | P/C | 13.95 | EPS past 3/5Y | - -62.61% | ROE | 1.41% | 52W High | -13.72% ($192.85) | Perf Year | 38.53% |
| Cash/sh | 11.93 | P/FCF | 27.23 | Sales past 3/5Y | -0.68% 11.9% | ROIC | 0.88% | 52W Low | 46.77% ($113.37) | Perf 3Y | 67.09% |
| Dividend Est. | - | EV/EBITDA | 14.76 | EPS Y/Y TTM | 179.33% | Gross Margin | 34.5% | Volatility(W/M) | 3.38% 2.78% | Perf 5Y | -27.73% |
| Dividend TTM | - | EV/Sales | 2.38 | Sales Y/Y TTM | -8.84% | Oper. Margin | 6.68% | ATR (14) | 5.03 | Perf 10Y | 20.28% |
| Dividend Ex-Date | - | Quick Ratio | 1.17 | EPS Q/Q | -46.71% | Profit Margin | 1.39% | RSI (14) | 54.91 | Recom | 1.25 |
| Dividend Gr. 3/5Y | - | Current Ratio | 2.39 | Sales Q/Q | 0.64% | SMA20 | 2.55% ($162.25) | Beta | 0.89 | Target Price | $195.57 |
| Payout | - | Debt/Eq | 0.6 | Earnings | 2026/11/5 | SMA50 | 0.86% ($164.97) | Rel Volume | 0.58 | Prev Close | $163.2 |
| Employees | 13000 | LT Debt/Eq | 0.58 | EPS/Sales Surpr. | 23.85% 2.71% | SMA200 | 12.11% ($148.42) | Avg Volume(3M) | 0.27M | Price | $166.39 |
| IPO | 1992/3/31 | Option/Short | Yes/Yes | Trades | 5136 | Volume | 155,832 | Change | 1.95% |
A U.S. medical device company that supplies IV infusion systems and medical consumables. It provides hospitals with medical devices and consumables, including infusion pumps, IV administration sets, and critical care monitoring products, and is characterized by recurring consumables revenue. The company operates in the IV infusion and medical consumables sector.
Over the past 1 year, roughly in the middle
14% below its 1-year high.
Traded less than usual. That is 58% of its average volume.
Next earnings report: November 5
8 days to go.
ICUI earns at a steady pace
Of every $100 in sales, $6.68 is kept as operating profit.
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by +12.6% this year.
Tap to view numbers
The price is about the industry average
Counting its debt, for $100 of yearly operating cash you would pay $1,476. Peers typically go for $1,598. It is about in line with its own 2-year average.
Tap to view numbers
It has beaten expectations every time
Beat market estimates in the last 4 quarters.
Tap to view numbers
The outlook is positive
Analyst sentiment is Strong Buy.
Tap to view numbers
Holding long would have lost money
Bought 5 years ago, your return today would be -27.7%. The S&P 500 did +69% over the same period.
Tap to view numbers
No dividend
It reinvests profits in the business instead of paying dividends.
Ownership looks stable
Institutions hold 104.7%.
Tap to view numbers
Multiple ETFs hold this stock, but only a sliver
Buying this ETF gives you exposure to this stock as well.
It ranks #19 of 51 in the industry
Based on market cap of $4B.
MMED#17 MiniMed Group Inc $5B PER - 
STVN#18 Stevanato Group Spa $5B PER 33.8 ICUI#19 ICU Medical Inc $4B PER 140.6 
PLSE#20 Pulse Biosciences Inc $4B PER - 
NVST#21 Envista Holdings Corp $4B PER 41.6 
FAQ
What kind of company is ICUI?
ICUI belongs to the Healthcare sector and operates in the Medical Instruments & Supplies industry.
What is the market cap of ICUI?
The market cap of ICUI is approximately $4.2B, ranking 1,506 within its sector.
What is the P/E ratio of ICUI?
ICUI has a P/E ratio of approximately 140.6x, which can be used to assess its valuation relative to the Healthcare sector average.
What is the 52-week high and low for ICUI?
ICUI has recorded a 52-week high of $192.85 and a low of $113.37.
